Cordyceps militaris Fruit Body Extract Decreases Testosterone Catabolism and Testosterone-Stimulated Prostate Hypertrophy

The androgens testosterone and dihydrotestosterone (DHT) are essential for a variety of systemic functions in mature males. Alteration of these hormones results in late-onset hypogonadism (LOH) and benign prostate hyperplasia (BPH). The fruit bodies of fungi of the genus Cordyceps have been regarded as folk medicine or health food with tonic and antifatigue effects. The extract from the fruit body of Cordyceps militaris parasitizing Samia cynthia ricini (CM) was evaluated as a novel-candidate natural product for ameliorating male andropause symptoms. To explore the effects of CM on LOH and BPH, CM was applied to rat models and cultured testicular cells and prostate cells. The concentrations of androgens in the serum and culture media were determined by ELISA. Expression of steroidogenic enzymes and androgen-related genes was evaluated by qPCR, and prostatic cell proliferation was assessed with the cell-viability assay. CM maintained the serum levels of testosterone and DHT, but inhibited testosterone-induced prostate hypertrophy. CM also increased the secretion of testosterone and DHT by primary testicular cells, with no changes in the mRNA expression of steroidogenic enzymes, but decreased the growth of prostatic cell lines. Our data suggest that CM could improve both LOH and BPH in males.     

经尿道前列腺电汽化切除术

目的 :探讨经尿道前列腺汽化切除术 (TUVP)治疗前列腺增生症的效果及安全性。方法 :采用经尿道前列腺汽化切除术治疗前列腺增生患者 12 0例经尿道前列腺汽化切除术。结果 :手术时间平均 5 8分钟 ,平均出血 40ml,术后保留尿管平均 3 8天 ,排尿通畅。随访 3月～ 2年 97例 ,I-PSS从 30 5 3下降到 9 3分 ,最大尿流率从 9 6ml/秒增加到 2 2 6ml/秒。结论 :TUVP具有操作简便、出血少、视野清晰、疗效确切、并发症少等优点 ,是一种安全有效的治疗技术。     

经尿道前列腺气化术治疗前列腺增生症（附60例报道）

目的：观察经尿道气化术治疗前列腺增生症（BPH）的近期疗效。方法：应用经尿道前列腺气化术治疗BPH60例。结果：60例患手术均成功。手术时间20－＃120min。术中心电图、血压无改变。结论：认为经尿道前列腺气化术（TUVP）损伤小、安全性高、疗效确切且并发症少,尤其适用于有严重并发症的高危患,TUVP治疗BPH近期效果好,其远期效果有待进一步随访观察。     

血管影像在乳腺癌诊断中的重要作用(附100例乳腺癌及200例良性乳腺增生对照分析)

[目的 ]提高对乳腺病血管像的认识 ,进而提高对乳腺良恶性病的诊断率。 [方法 ]选取经手术病理证实为乳腺癌的病例 1 0 0例 ,从乳腺体检中发现或经追踪观察为乳腺轻度增生的病例 2 0 0例乳腺 X线影像进行对照分析。 [结果 ]乳腺恶性与良性病变在血管像上有一定区别 :1血管像增粗。血管像横径大于2 .0 mm为增粗 ,乳腺恶性病变有 76例 ( 76.0 % ) ,良性病变有 40例 ( 2 0 .0 % ) ;2血管像增多。血管像条数多于 3条为增多 ,乳腺恶性病变有 61例 ( 61 .0 % ) ,乳腺良性病变有 46例 ( 2 3.0 % ) ;3血管像增大。弯曲度小于 1 5 0°血管像迂曲明显 ,乳腺恶性病变有 83例 ( 83.0 % ) ,乳腺良性病变有 42例 ( 2 1 .0 % ) ;4血管像走行特点。呈花瓣状 ,恶性病变有 33例 ( 33.0 % ) ,良性病变有 2例 ( 1 .0 % ) ;呈残端状 ,恶性病变有 34例 ( 34.0 % ) ,良性病变有 3例 ( 1 .5 % ) ;呈放射状 ,恶性病变有 1 3例 ( 1 3.0 % ) ,良性病变有 1例( 0 .5 % )。 [结论 ]掌握乳腺病血管像的特征 ,可以帮助确定乳腺病病变性质 ,提高对隐性癌和微小癌的诊断率和治愈率 ,从而延长生存期     

前列腺增生症伴有神经源性排尿功能障碍的处理

目的：提高对前列腺增生症伴有神经源性排尿功能障碍的认知和处理水平。方法：回顾分析14例前列腺增生症伴有神经源性排尿功能障碍患者的临床资料、尿动力学检查、诊断、处理及预后情况。结果：14例中行前列腺电气化9例,趾骨上经膀胱前列腺摘除术1例,膀胱永久造瘘2例,药物保守治疗2例。电气化患者1例出现永久性尿失禁,1例术后1年又出现增生,经再次气化治疗后痊愈,其余患者排尿均明显改善,残余尿减少或消失。结论：前列腺增生症伴有原性尿功能障碍并不少见,通过细致的检验和尿动力学检查,明确神经性排尿功能障碍的严重程度,选择恰当的治疗方案能够改善排尿症状,减少永久膀胱造瘘,最大限度地提高病人的生活质量。     

Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance

Nonalcoholic fatty liver disease (NAFLD), the liver component of metabolic syndrome, is considered to be associated with high risk of prostatic diseases but a systematic review has not been conducted. Under a comprehensive review of the eligible clinical studies, a potential positive association between NAFLD and benign prostatic hyperplasia/prostate cancer (BPH/PCa) has been postulated. Insulin resistance and metabolic aberrations are considered to be the potential mechanism for such association. However, the relationship between NAFLD and other prostatic diseases, that is, prostatic inflammation and lower urinary tract symptoms, seems vague due to limited relevant studies in the literatures. The present review highlights that clinicians should be conscious of the detrimental effect of NAFLD on the development of BPH and PCa.     

Is ‘Omega Sign’ anatomical endoscopic enucleation of the prostate technique reproducible?

We aimed to evaluate the learning curve of the surgically standardised ‘Omega Sign’ anatomical endoscopic enucleation (AEEP) of the prostate surgery technique for junior surgeons. This study is a retrospective comparison of cases that underwent AEEP by a mentor surgeon and three junior surgeons who have completed their learning curve. A video-based laser enucleation of the prostate assessment tool (LEAT) composed of 8 steps of the technique was used to assess a senior surgeon and junior surgeons’ surgical compatibility and consistency. The surgeon who defined Omega Sign technique was determined as group 1, and cases by three junior surgeons were identified as group 2. The end points were to assess the reproducibility and repeatability and operative post-operative outcomes of the technique. 55 patients’ videos were rated by five experienced endourologists. There was no significant difference in LEAT scores between the groups among all steps. The most symmetry was found in the 1st and 3rd steps. Inter-rater consistency was also high for each step, with no statistically significant difference between the evaluators. The standardised anatomical ‘Omega Sign’ technique is reproducible for the junior surgeons. The operative steps can be performed with high consistency, and the functional and perioperative outcomes are comparable with the senior surgeon.     

Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis

We conducted a systematic review and meta-analysis to assess the outcomes and complications of naftopidil in treating elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and compared them with those administered with tamsulosin. A literature review was performed to identify the available randomised controlled trials concerning the comparison between naftopidil and tamsulosin for men with LUTS/BPH. We searched the following databases: the Cochrane Library Database, PubMed, Embase and Web of Science. Eleven publications involving 1,114 men (557 in the naf group and 557 in the tam group) were pooled in our analysis. We found no significant differences in the total IPSS, IPSS storage score, IPSS voiding score, quality of life index, peak urinary flow rate, average flow rate and post-void residual volumes. We assessed cardiovascular and sexual adverse events, acute urinary retention, surgical intervention, withdrawals due to any reason and withdrawals due to adverse events. The incidence of adverse events was similar among patients in naf and tam groups. In conclusion, naftopidil shared comparable efficacy and similar incidence of adverse events with tamsulosin and appears to be a promising agent for and alternative to tam. However, more prospective trials with high quality and long-term treatment duration are needed to verify this observation.     

Is there relationship between serum uric acid levels and lower urinary tract symptoms,prostate volume,and PSA in men without cancer? A prospective population-based study

There are conflicting results about uric acid (UA) effect on the prostate. We investigated the relationship between UA and PSA, free PSA, prostate volume and international prostate symptoms score (IPSS) in benign prostate hyperplasia (BPH). This study was conducted in BPH men without cancer who were referred for annual health workup (N = 910) from 2017 to 2020. The mean ages were 67.28 ± 9.2 years. UA was positively related to IPSS and PSA (r = 0.210, p = .023 and r = 0.156, p = .041 respectively) and also negatively related to free/total PSA ratio (r = −0.332, p = .01) but not related to prostate volume (r = 0.036, p = .696). After adjustment for age, BMI and prostate volume, there were significant relationships between hyperuricaemia and PSA, free/total PSA ratio, and IPSS (95% CI: 0.254–1.645, OR = 0.647, p = .039; 95% CI: 0.076–0.899, OR = 0.270, p = .033 and 95% CI: 1.011–3.386, OR = 1.851, p = .038 respectively). These results should be considered during the general assessment of the patients with BPH. The findings raise the possible hypothesis of relationship between serum UA with IPSS and PSA which should be investigated by future studies.